277 related articles for article (PubMed ID: 30469504)
1. 2D- and 3D-Based Intestinal Stem Cell Cultures for Personalized Medicine.
Liu Y; Chen YG
Cells; 2018 Nov; 7(12):. PubMed ID: 30469504
[TBL] [Abstract][Full Text] [Related]
2. From 3D to 2D: Harmonization of Protocols for Two-dimensional Cultures on Cell Culture Inserts of Intestinal Organoids from Various Species.
Warschkau D; Delgado-Betancourt E; Holthaus D; Müller A; Kliem G; Krug SM; Schulzke JD; Aebischer T; Klotz C; Seeber F
Bio Protoc; 2022 Jan; 12(2):e4295. PubMed ID: 35127985
[TBL] [Abstract][Full Text] [Related]
3. Application of Patient-Derived Cancer Organoids to Personalized Medicine.
Shiihara M; Furukawa T
J Pers Med; 2022 May; 12(5):. PubMed ID: 35629212
[TBL] [Abstract][Full Text] [Related]
4. Organoid Culture of Isolated Cells from Patient-derived Tissues with Colorectal Cancer.
Xie BY; Wu AW
Chin Med J (Engl); 2016 Oct; 129(20):2469-2475. PubMed ID: 27748340
[TBL] [Abstract][Full Text] [Related]
5. Establishment of patient-derived three-dimensional organoid culture in renal cell carcinoma.
Na JC; Kim JH; Kim SY; Gu YR; Jun DY; Lee HH; Yoon YE; Choi KH; Hong SJ; Han WK
Investig Clin Urol; 2020 Mar; 61(2):216-223. PubMed ID: 32158973
[TBL] [Abstract][Full Text] [Related]
6. Hydrogel-based colorectal cancer organoid co-culture models.
Luo X; Fong ELS; Zhu C; Lin QXX; Xiong M; Li A; Li T; Benoukraf T; Yu H; Liu S
Acta Biomater; 2021 Sep; 132():461-472. PubMed ID: 33388439
[TBL] [Abstract][Full Text] [Related]
7. Prospective derivation of a living organoid biobank of colorectal cancer patients.
van de Wetering M; Francies HE; Francis JM; Bounova G; Iorio F; Pronk A; van Houdt W; van Gorp J; Taylor-Weiner A; Kester L; McLaren-Douglas A; Blokker J; Jaksani S; Bartfeld S; Volckman R; van Sluis P; Li VS; Seepo S; Sekhar Pedamallu C; Cibulskis K; Carter SL; McKenna A; Lawrence MS; Lichtenstein L; Stewart C; Koster J; Versteeg R; van Oudenaarden A; Saez-Rodriguez J; Vries RG; Getz G; Wessels L; Stratton MR; McDermott U; Meyerson M; Garnett MJ; Clevers H
Cell; 2015 May; 161(4):933-45. PubMed ID: 25957691
[TBL] [Abstract][Full Text] [Related]
8. Tumor organoid model of colorectal cancer (Review).
Yang C; Xiao W; Wang R; Hu Y; Yi K; Sun X; Wang G; Xu X
Oncol Lett; 2023 Aug; 26(2):328. PubMed ID: 37415635
[TBL] [Abstract][Full Text] [Related]
9. Biomaterials for intestinal organoid technology and personalized disease modeling.
Hirota A; AlMusawi S; Nateri AS; Ordóñez-Morán P; Imajo M
Acta Biomater; 2021 Sep; 132():272-287. PubMed ID: 34023456
[TBL] [Abstract][Full Text] [Related]
10. Establishment and characterization of meningioma patient-derived organoid.
Chan HSC; Ng HK; Chan AK; Cheng SH; Chow C; Wong N; Wong GKC
J Clin Neurosci; 2021 Dec; 94():192-199. PubMed ID: 34863437
[TBL] [Abstract][Full Text] [Related]
11. Importance of organoids for personalized medicine.
Perkhofer L; Frappart PO; Müller M; Kleger A
Per Med; 2018 Nov; 15(6):461-465. PubMed ID: 30418092
[TBL] [Abstract][Full Text] [Related]
12. Studying Human Neurological Disorders Using Induced Pluripotent Stem Cells: From 2D Monolayer to 3D Organoid and Blood Brain Barrier Models.
Logan S; Arzua T; Canfield SG; Seminary ER; Sison SL; Ebert AD; Bai X
Compr Physiol; 2019 Mar; 9(2):565-611. PubMed ID: 30873582
[TBL] [Abstract][Full Text] [Related]
13. Patient-Derived Organoids of Colorectal Cancer: A Useful Tool for Personalized Medicine.
Kiwaki T; Kataoka H
J Pers Med; 2022 Apr; 12(5):. PubMed ID: 35629118
[TBL] [Abstract][Full Text] [Related]
14. Comparison of Cell and Organoid-Level Analysis of Patient-Derived 3D Organoids to Evaluate Tumor Cell Growth Dynamics and Drug Response.
Kim S; Choung S; Sun RX; Ung N; Hashemi N; Fong EJ; Lau R; Spiller E; Gasho J; Foo J; Mumenthaler SM
SLAS Discov; 2020 Aug; 25(7):744-754. PubMed ID: 32349587
[TBL] [Abstract][Full Text] [Related]
15. Establishment of 3D Intestinal Organoid Cultures from Intestinal Stem Cells.
Sugimoto S; Sato T
Methods Mol Biol; 2017; 1612():97-105. PubMed ID: 28634937
[TBL] [Abstract][Full Text] [Related]
16. Organoids and Colorectal Cancer.
Barbáchano A; Fernández-Barral A; Bustamante-Madrid P; Prieto I; Rodríguez-Salas N; Larriba MJ; Muñoz A
Cancers (Basel); 2021 May; 13(11):. PubMed ID: 34071313
[TBL] [Abstract][Full Text] [Related]
17. Disease Modeling Using 3D Organoids Derived from Human Induced Pluripotent Stem Cells.
Ho BX; Pek NMQ; Soh BS
Int J Mol Sci; 2018 Mar; 19(4):. PubMed ID: 29561796
[TBL] [Abstract][Full Text] [Related]
18. Generation of human liver organoids from pluripotent stem cell-derived hepatic endoderms.
Kulkeaw K; Tubsuwan A; Tongkrajang N; Whangviboonkij N
PeerJ; 2020; 8():e9968. PubMed ID: 33133779
[TBL] [Abstract][Full Text] [Related]
19. Cryopreservation of Viable Human Tissues: Renewable Resource for Viable Tissue, Cell Lines, and Organoid Development.
He A; Powell S; Kyle M; Rose M; Masmila E; Estrada V; Sicklick JK; Molinolo A; Kaushal S
Biopreserv Biobank; 2020 Jun; 18(3):222-227. PubMed ID: 32302515
[TBL] [Abstract][Full Text] [Related]
20. Using 3D Organoid Cultures to Model Intestinal Physiology and Colorectal Cancer.
Short SP; Costacurta PW; Williams CS
Curr Colorectal Cancer Rep; 2017 Jun; 13(3):183-191. PubMed ID: 29276469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
